JUNE – JULY 2004 www.nexusmagazine.com NEXUS • 25

The medical profession takes much pride in the rigorous scientific research thatunderpins its approach to cancer treatment. Someone newly diagnosed with cancerfaces enormous pressure from our health care system to start immediately on a sci-entific medical treatment program that involves surgery, chemotherapy and radiation

in various combinations. Being fearful and in shock, most individuals in this situation are nomatch for the overwhelming power of medical authority.

How would you react in this situation? You may be leaning towards natural therapies forsimple health problems, but for something as serious as cancer you may feel safer with thetested and proven methods of orthodox medical care. Nevertheless, if you have the chance,read the following before you make your final decision. You may then have a betterappreciation of natural cancer treatment.

In this article I have assembled some little-known facts about the science behind orthodoxcancer treatment. In cancer research, success—expressed as a five-year survival rate—isestablished by comparing other forms and combinations of treatment with the results fromsurgery alone. However, the success rate of surgery has rarely been compared with thesurvival rates of untreated patients and never with patients who adopted natural therapies.Therefore, orthodox cancer treatment is basically unscientific. The overall supposed cure rateis not higher than can be accounted for by spontaneous remissions and the placebo effect.

In support of my position, I offer the following key statements and conclusions frommedical and scientific publications.

"Studies a p p e a r to show that early intervention is helpful, because pre-cancerous lesionsare included in early removals that frequently would n o t become cancerous if left untouched[author’s emphasis]." In other words, early intervention a p p e a r s to be helpful becauselesions are removed that are not cancerous but are counted as being cancer, and that improvesthe survival statistics. "Also, it does not matter how much or how little of a breast isremoved; the outcome is always the same."1 This statement indicates that surgery does notimprove survival chances, otherwise there would be a difference between radical surgery andl u m p e c t o m y .

Researchers have said it is complacent to continue subjecting at least 70% of women withbreast cancer to a futile mutilating procedure.2 Furthermore, there is no evidence that earlymastectomy affects survival; if patients knew this, they would most likely refuse surgery.3

In 1993, the editor of the L a n c e t pointed out that, despite various modifications of breastcancer treatment, death rates remained unchanged. He acknowledged that despite the almostweekly releases of miracle breakthroughs, the medical profession with its extraordinarycapacity for self-delusion (his words, not mine) in all truth has lost its way. At the same time,he rejected the view of those who believe that salvation will come from increasingchemotherapy after surgery to just below the rate where it kills the patient. He asked, "Wouldit not be more scientific to ask why our approach has failed?" Not too soon to ask thisquestion after a century of mutilating women, I would say. The title of this editorial,appropriately, is "Breast cancer: have we lost our way?"4

Basically, all types and combinations of conventional breast cancer treatment appear toresult in the same l o w long-term survival rates. The only conclusion that can be drawn fromthis is that conventional treatment does not improve long-term survival rates. Even worse,Michael Baum, MD, a leading British breast cancer surgeon, found that breast cancer surgerytends to increase the risk of relapse or death within three years. He also linked surgery toaccelerating the spread of cancer by stimulating the formation of metastases in other parts ofthe body.5

Research studiesand unbiased

statistical analysisshow that there isno scientific basis

for orthodox cancertreatments likeradical surgery,

chemotherapy andradiation therapy

and that thesetreatments often do

more harm thangood.

by Walter Last © 2004

Website:

http://www.health-science-spirit.com

An earlier German comparison found that untreated post-menopausal women with breast cancer live longer than treatedwomen, and the recommendation was not to treat postmenopausalwomen for breast cancer.6 This conclusion confirms a finding byErnst Krokowski, a German professor of radiology. He demonstratedconclusively that metastasis is commonly triggered by medical inter-vention, including sometimes even by a biopsy or surgery unrelatedto the cancer.7 Disturbance of a tumour causes a greatly increasednumber of cancer cells to enter the bloodstream, while most medicalintervention (especially chemotherapy) suppresses the immune sys-tem. This combination is a recipe for disaster. It is the metastasesthat kill, while primary tumours in general, and those in the breast inparticular, can be relatively harmless. These findings have been con-firmed by recent research which shows that surgery, even if unrelatedto the cancer, can trigger an explosive spread of metastases and leadto an untimely end.8

This follows earlier reports that radical surgery for prostate canceralso tends to spread the disease. Actually, prostate cancer wasinvestigated in the first randomised clinical trials for any type ofcancer. After 23 years, there was nodifference in the survival rates of thosewho had surgery and the controls whodid not have surgery, but those withsurgery suffered more morbidity such asimpotence or incontinence.9

The late H. B. Jones, Professor ofMedical Physics, was a leading US can-cer statistician. He said in a speechbefore the American Cancer Society in1969 that no study has proved that earlyintervention improves the chances of sur-vival. On the contrary, his studiesproved conclusively that untreated can-cer victims live up to four times longerand with better quality of life than treatedo n e s .1 0 Needless to say, he was not invited again.

Massaging StatisticsAn epidemiological study confirmed the questionable value of

conventional therapy by concluding that "medical interventions forcancer have had a negligible or no effect on survival".1 1 Even theconservative New England Journal of Medicine had an article withthe headline, "Cancer Undefeated".1 2

Common ways to make medical statistics look more favourableare as follows. Patients who die during prolonged treatment withchemotherapy or radiotherapy are not counted in the statisticsbecause they did not receive the full treatment. In the control group,everyone who dies is counted.

Furthermore, success commonly is judged by the percentage ofshrinking tumours, regardless of patient survival; but if the rate orlength of survival is measured, then it is usually only in terms ofdying from the treated disease. It is not normally shown how manyof the patients die due to the treatment itself.

The current trend is to pick up pre-cancerous conditions very earlyand treat them as cancer. While this statistically increases thenumber of people with cancer, it also artificially prolongs survivaltimes and lowers death rates, thereby making medical treatmentsappear to be more successful. However, there may also be a genuinecomponent of improved survival, as increasing numbers of cancerpatients opt for additional natural therapies.

An investigation of the records of 1.2 million cancer patientsrevealed that the death rate attributed to non-cancer death shortlyafter treatment was 200% higher than would normally be expected.

Two years after diagnosis and treatment, this excess death rate hadfallen to 50%. The most common cause for the excess death ratewas listed as heart and respiratory failure. This means that, insteadof dying several years later from cancer, these patients died from theeffects of the treatment and helped greatly improve the cancerstatistics because they did not strictly die of cancer. 1 3 T h i smisleading reporting of cancer deaths has led to demands for morehonest statistics.1 4

After an analysis of several large mammogram-screening studiesfound that mammography leads to more aggressive treatment withno survival benefits, even the editor of the L a n c e t had to admit thatthere is no reliable evidence from large randomised trials to supportmammography screening programs.1 5 The significance of this state-ment goes far beyond the use of mammograms.

It is openly acknowledged by the proponents of conventionalmedicine that they have no effective way of helping patients withadvanced cancer. Until now, the catchcry has always been "Detect itearly, then it can be cured". These mammogram evaluation studiesdemonstrate that it does not matter when cancer is detected; the

conventional methods are useless, as isthe whole multibillion-dollar cancerindustry (my conclusion).

A 13-year Canadian study involving40,000 women compared physicalbreast examinations with examinationsplus mammograms. The mammogram-plus-examination group had many morelumpectomies and surgeries, with adeath rate of 107 compared with 105deaths in the physical examinationg r o u p .1 6

Ductal carcinoma in situ (DCIS) is acommon, non-invasive form of breasttumour. Most cases of DCIS aredetected through the use of

mammography. In younger women, 92% of all cancers detected bymammography are of this type. Nevertheless, on average, 44%—and in some areas 60%—of these are treated by mastectomy. Asmost of these tumours are harmless, this needless treatment makessurvival statistics appear to be better than they actually are.1 7

While conventional diagnosis is invasive and may help to spreadthe cancer, a kind of electrodermal screening—called the Biofieldtest—developed by a team from eight European hospitals and uni-versities, was reported in the L a n c e t as being 99.1% accurate indiagnosing malignancy in breast tumours.1 8

A large meta-analysis of radiotherapy results for lung cancershowed that after two years there were 21% more deaths in thegroup that had radiotherapy in addition to surgery as compared tothose who had surgery alone. The L a n c e t a r t i c l e1 9 stated that therationale is to kill any cancer cells remaining after surgery, but it is ashame that the facts do not agree with this theory.

Chemotherapy: Medical Russian RouletteChemotherapy for children with leukaemia and Hodgkin's disease

is the proud showpiece of the arguably only apparent success oforthodox cancer therapy. Now a long-term follow-up study showsthat such children develop 18 times more secondary malignanttumours later in life. Even worse, girls face a 75 times (7,500%)higher risk of breast cancer by the time they are forty.2 0 A mainproblem appears to be the development of deep or systemic C a n d i d aa l b i c a n s infections shortly after commencement of chemotherapy.2 1

If these infections are not appropriately treated, then relapses orfuture health problems are likely to occur.

26 • NEXUS www.nexusmagazine.com JUNE – JULY 2004

After 23 years, there was nodifference in the survival rates

of those who had [prostatecancer] surgery and thecontrols who did not …

A study of ovarian cancer found that the risk of developingleukaemia after treatment with chemotherapy increased 21-fold or2,100%. Chemotherapy showed a clear dose-dependency wherebythe incidence of triggered leukaemia doubled between low-dose andmoderate-dose groups and then quadrupled between the moderate-dose and the high-dose groups. Also, other tumours commonlydevelop after treating malignancies with chemotherapy.2 2 In a trialfor multiple myeloma, no advantage was found by using chemother-apy as compared to no treatment.2 3

The respected German biostatistician Ulrich Abel presented acomprehensive analysis of over 3,000 clinical trials on the value ofchemotherapy for advanced carcinoma (for instance, breast cancer).(Oncologists tend to use chemotherapy because this may induce atemporary shrinking of the tumour, called a response; however, italso tends to produce unpleasant side effects.) Abel concluded thatthere is no direct evidence that chemotherapyprolongs survival in these cases. Abel stated:"Many oncologists take it for granted thatresponse to therapy prolongs survival, an opin-ion which is based on a fallacy and which isnot supported by clinical studies."2 4

Ralph W. Moss, PhD, in Q u e s t i o n i n gC h e m o t h e r a p y, provides a detailed analysis ofthis subject. The overall conclusion of thebook is that there is no evidence in terms ofthe majority of cancers that chemotherapyextends life.2 5

However, even if chemotherapy couldextend life for a few months, what about thequality of this life? Tom Nesi, a formerDirector of Public Affairs at the pharma-ceutical giant Bristol-Myers Squibb,wrote in the New York Times about thesuccessful treatment of his wife, whichstatistically extended her life for threem o n t h s .2 6 Two weeks after the treat-ment, she scribbled on a notepad:"depressed—no more—please". I amnot surprised about reports that mostoncologists would not have their ownfamily members use these treatments.

The Full TreatmentVirginia Livingston (later Livingston-

Wheeler), a remarkable cancerresearcher and therapist, in her book, Cancer: A New Breakthrough,gives an account of one of the many patients she saw who had cometo her only after receiving the full medical treatment for breast can-c e r :2 7

"After discovering a small breast lump, she had radical mastecto-my. None of the lymph nodes removed from the armpit [was]involved; all of the cancer had been successfully removed. To makeextra sure that there was no regrowth in the scars, she received radia-tion treatment, and also her ovaries were taken out.

"To her dismay, a year later several small nodules appeared in theold breast scar. Again she received radiation. More lumps appearedon the neck that called for still more radiation. In addition, shereceived male hormone therapy, resulting in acne and coarse facialhair. Still the nodules came back. Now she received chemotherapywith the usual side effects.

"Before her hair could regrow, pain in her bones was diagnosed asbone cancer. More chemotherapy and hormone therapy wasexpected to help. However, several months later the bone lesions

became worse and removal of her adrenal glands was recommendedand performed. Hopefully, that would prolong her suffering foranother year. After that, the removal of her pituitary gland mightgive her a further three to six months to live.

"By now her faith in her medical advisers was sufficiently shakenthat she came to Dr Livingston for help. She asked to be examinedwithout her husband being present, as she wanted to spare him theagony of seeing her naked body, distorted, mutilated and shrunkenwith an immensely swollen abdomen and thin legs. Finally shewhispered: 'Doctor, shall I kill myself?'"

A Conspiracy of SilenceWhy are they doing this? (By "they", I am referring to what is

commonly called "the Cancer Establishment".) I believe the answerwas given by the eminent medical commentator and former editor of

New Scientist, Dr Donald Gould, in a timelessarticle called "Cancer: A Conspiracy ofS i l e n c e " .2 8 The subtitle summarises his posi-tion: "The commonest cancers are as resistantto treatment today as they were 40 or 50 yearsago. Nothing is to be gained by pretendingthat the battle against cancer is slowly butsurely being won."

This truth has been deliberately concealedfrom the general public. According to Gould,the reason for this conspiracy of silence ismoney. The public must continue to see theCancer Establishment as a winner to continueproviding money. One of the quoted scientistssaid that with tens of thousands of radiologists

and millions of dollars in equipment, onejust gives radiation treatment even ifstudy after study shows that it does moreharm than good.

Gould also is of the opinion thatpatients who could be comfortable with-out medical treatment until theirinevitable death, w i t h medical treatmentare made miserable in a pointless attemptto postpone death for a few unhappyweeks. But, of course, that is when mostof the money is being made. Gould feelsthat they poison their patients with drugsand rays and mutilate them with unnec-essary surgery in a desperate attempt to

treat the untreatable. Not much has changed since Gould wrote this article in 1976. In

a recent edition of The Moss Reports, we can read that long-termsurvival from common cancers such as prostate, breast, colorectaland lung "has barely budged since the 1970s".2 9 In summary, thismeans that there has been no significant improvement in cancer sur-vival rates in the last 70 to 80 years.

The Scientific Basis for Drug ApprovalsIt is also interesting to know the scientific basis for the approval of

cancer drugs. Most of these drugs come initially from the USA. Inthe past, a company had to submit two favourable, large randomisedtrials to obtain US Food and Drug Administration (FDA) approval."Favourable" means that there must be a certain rate of tumourshrinkage lasting for at least one month. It was not necessary toshow that the treatment prolonged survival, and it was not necessaryto submit the results of any unfavourable trials for the same drug.

These "strict scientific" guidelines were relaxed in the Clinton era,

JUNE – JULY 2004 www.nexusmagazine.com NEXUS • 27

"Many oncologists take it for granted that

response to therapyprolongs survival,

an opinion which isbased on a fallacy andwhich is not supported

by clinical studies."

and drug companies can get FDA approval on the basis of small pre-liminary trials, even if a large randomised trial may beu n f a v o u r a b l e .3 0 In a remarkable statement about drug approvals, anFDA spokesperson pointed out that any delay in approval did notmean unnecessary deaths because "all these treatments for advancedcancer don't cure people".3 1

Perhaps the situation is even worse than a case of just ineffectivetreatments. A group of respected researchers reviewed all the pub-lished statistical evidence on the outcome of medical treatments, andshowed that the medical system is now the leading cause of deathand injury in the USA. Deaths attributable to heart disease in 2001were 699,697, for cancer the figure was 553,251, while for medicalinterventions it was 783,936 per year! Appropriately, the title of thisstudy is "Death by Medicine".3 2

You may wonder why health authorities turn a blind eye to thesemassive fatalities, mostly caused by drugs, while concentrating theirenergies instead on suppressing food supplements and natural reme-dies.

A symptom of this official attitude is therecent saga of Pan Pharmaceuticals, when in2003 the Australian government forced thelargest local manufacturer of natural remediesinto bankruptcy, allegedly because there was apossibility that these products might causesomeone to get sick or even die.

In my view, a main reason for this distortedofficial attitude is the fact that health depart-ments and regulatory authorities are dominatedby medical doctors who have been trained(partly with money from drug companies) tobelieve that drugs are beneficial and naturalremedies are potentially harmful. Despite amajority of Western populations prefer-ring natural remedies, basically allpolitical parties promote dependency onpharmaceutical drugs.

Therefore, as a first step to changingthis oppressive political climate, weurgently need a political party that pro-motes natural health care rather than drugdependency.

We can find a clue for the cause ofthese appalling "Death by Medicine" sta-tistics in an editorial by Richard Smith inthe British Medical Journal: "Yet only15% of medical interventions are sup-ported by solid scientific evidence" and"This is because only 1% of the articles in medical journals are sci-entifically sound, and partly because many treatments have neverbeen assessed at all".3 3

A good demonstration of the unscientific nature of medicalresearch is the recent fiasco with hormone replacement therapy(HRT). Several decades ago, it was shown in "rigorous scientific"research to be safe and effective; otherwise it would not have beenapproved. It was strongly promoted as protecting against heart dis-ease and cancer. Now every new trial shows HRT to be dangerousand to increase the risk of developing heart disease and cancer.

What went wrong? Why was this not picked up earlier? Quitesimply, the original research was conducted with the aim of generat-ing profits, while recent researchers are not sharing in any of theseprofits. Therefore, I mistrust any research that is conducted withprofit in mind. Unfortunately, this presently applies to most medicalr e s e a r c h .

The Way ForwardIt is now 32 years since President Nixon declared war on cancer.

Since then, US$2 trillion has been spent on conventional cancertreatment and research, with the result that more individuals aredying from cancer than ever before.3 4 While there have been manystudies to evaluate the effects of various nutrients on differentcancers, nothing of these two trillion dollars has been available fornatural therapists to conduct trials of holistic cancer therapies.Natural therapists have had to face a century of persecution, many ofthem being dragged before courts and ending up in jail.

Would it not be more scientific to evaluate the methods of naturalcancer therapists impartially rather than put the therapists in jail?Most alternative cancer clinics in the USA have had to relocate toMexico. (For a list of such clinics worldwide, see the websitehttp://www.cancure.org.)

An holistic cancer approach includes superior nutrition, herbs,electromedicine and vibrational or energy medicine, emotional heal-

ing and mind therapy. The only reportedstudy that comes close to investigating anholistic approach involves the Gerson therapyin an evaluation of five-year survival rates of153 melanoma patients. Here, 100% ofGerson therapy patients with Stage I and IIcancers survived, but only 79% survived whohad conventional therapy. With Stage III can-cers (regional metastases), the figures respec-tively were 70% and 41%; with Stage IVa(distant metastases), 39% with Gerson and 6%with conventional therapy survived.3 5

Many natural cancer therapists claim a suc-cess rate of more than 90% in arresting andreversing cancer, provided that patients have

not been subjected to orthodox treat-ments beforehand. The most damagingtreatments appear to be chemotherapyand radiotherapy.

Therefore, if you are confronted withcancer, I suggest that you resist actingout of fear and under pressure. Thesituation is hardly ever so urgent that youhave to act immediately. Instead, doyour own research from books, journalsand the Internet, and then trust yourcommon sense or intuition. ∞

About the Author:Walter Last worked as a biochemist and

research chemist in the medical departments of several German univer-sities and at Bio-Science Laboratories in Los Angeles, USA. Later heworked as a nutritionist and natural therapist in New Zealand and inAustralia, where he is now based.

He has written numerous health-related journal articles as well asseveral books, including Heal Yourself and Healing Foods ( P e n g u i nBooks). His new book, The Natural Way to Heal (Hampton RoadsPublishing, 2004), is reviewed in this issue. His article, "The NewMedicine of Dr Hamer", about Dr Ryke Geerd Hamer's discovery of theshock-conflict mechanism underlying cancer development, was pub-lished in NEXUS 10/05.

Walter Last is retired and does not have a clinic. For information onhealth questions, see his website http://www.health-science-spirit.com;for his approach to cancer treatment, click on "Diseases" to find hiseight-part article, "Overcoming Cancer".

28 • NEXUS www.nexusmagazine.com JUNE – JULY 2004

Continued on page 75

Despite a majority ofWestern populations

preferring naturalremedies, basically all political parties

promote dependency on pharmaceutical

drugs.

E n d n o t e s1 . Skrabanek, P., "False Premises and False Promises ofBreast Cancer Screening", The Lancet 2:316-19 (1985)2 . Baum, M., "The Curability of Breast Cancer", B r i t i s hMedical Journal1:439-42 (1976)3 . Cunningham, L., "Mastectomy for so-called lobular car-cinoma in situ", The Lancet1(8163):306 (February 9, 1980)4 . Editorial, "Breast Cancer: Have we lost our way?", T h eL a n c e t 341:343-44 (1993)5 . Baum, M., "Does surgery disseminate or accelerate can-cer?", The Lancet 347:260 (January 27, 1996)6 . Gregl, A., "Die Lebenserwartung des unbehandeltenMammakarzinoms" ("The life expectancy of the untreatedmamma carcinoma [breast cancer]"), Klin. Wschr. 41:676( 1 9 6 3 )7 . Krokowski, E.H., "Is the Current Treatment of CancerSelf-Limiting in the Extent of its Success?", J. Int. Acad.Preventive Medicine6(1) 23-39 (1979)8 . Tagliabue, E. et al., "Role of HER2 in wound-inducedbreast carcinoma proliferation", The Lancet 3 6 2 : 5 2 7 - 5 3 3(August 16, 2003)9 . Iversen, P. et al., "Radical Prostatectomy versusExpectant Treatment for Early Carcinoma of the Prostate",Scand. J. Urol. Nephrol.172:65-72 (1995)1 0 . Jones, H.B., Lecture at the American Cancer SocietyConference, New Orleans, July 3, 19691 1 . McKinlay, J.B. et al., "A Review of the EvidenceConcerning the Impact of Medical Measures on RecentMortality and Morbidity in the United States",Int. J. HealthS e r v i c e s 19(23):181-208 (1989)1 2 . Bailar, J.C. III, Gornik, H.L., "Cancer undefeated",New England Journal of Medicine336:1569-1574 (1997)

1 3 . Brown, B.W., Brauner, C., Minnotte, M.C.,"Noncancer deaths in white adult cancer patients", J. Nat.Cancer Inst. 85:979-987 (1993) 1 4 . Welch, H.G., Black, W.C., "Are Deaths Within 1Month of Cancer-Directed Surgery Attributed to Cancer?",J. Nat. Can. Inst.94:1066-70 (2002) 1 5 . Olsen, O., Gotzsche, P.C., "Cochrane review on screen-ing for breast cancer with mammography", The Lancet358:1340-42 (October 20, 2001) and Editorial, pp. 1284-851 6 . Miller, A.B. et al., "Canadian National Breast CancerScreening Study–2: 13-year results of a randomised trial inwomen aged 50–59 years", J. Nat. Cancer Inst.9 2 : 1 4 9 0 - 9 9(Sept 20, 2000)1 7 . Ernster, Virginia L. et al., "Incidence of and treatmentfor ductal carcinoma in situ of the breast", Journal of theAmerican Medical Association275(12):913-18 (March 27,1 9 9 6 ) ;Page, David L., Jensen, Roy A., "Ductal carcinoma in situof the breast", J A M A, ibid., pp. 948-49 1 8 . Cuzick, Jack et al., "Electropotential measurements as anew diagnostic modality for breast cancer", The Lancet352:359-63 (August 1, 1998)1 9 . PORT Meta-analysis Trialists Group, "Postoperativeradiotherapy in non-small-cell lung cancer: systematicreview and meta-analysis of individual patient data fromnine randomised controlled trials", The Lancet352(9124):257-63,250-51 (July 25, 1998) 2 0 . Bhatia, S., Robison, L.L. et al., "Breast cancer andother second neoplasms after childhood Hodgkin's disease",New England J. Med.334(12):745-51 (March 21, 1996) 2 1 . Klingspor, L., Stintzing, G., Tollemar, J., "DeepC a n d i d a infection in children with leukaemia", A c t aP a e d i a t r . 86(1)30-6 (1997)2 2 . Klein-Szanto, A.J.P., "Carcinogenic effects ofchemotherapeutic compounds", Prog. in Clinical and

Biological Research374:167-74 (1992)2 3 . Riccardi, A., Mora, O. et al., "Long-term survival ofstage I multiple myeloma given chemotherapy just afterdiagnosis or at progression of the disease: a multicentrerandomised study", Br. J. Cancer82(7):1254-60 (April2 0 0 0 )2 4 . Abel, U., "Chemotherapy of advanced epithelial can-cer: a critical review", Biomed. Pharmacother.4 6 ( 1 0 ) : 4 3 9 -52 (1992)2 5 . Moss, Ralph W., PhD, Questioning Chemotherapy,Equinox Press, NY, 19952 6 . Nesi, Tom, "False hope in a bottle" (Op. Ed.), N e wYork Times, June 5, 2003 2 7 . Livingston, Virginia, Cancer: A New Breakthrough,Cancer Book House, LA, 19722 8 . Gould, D., "Cancer: A Conspiracy of Silence", N e wS c i e n t i s t, 2 December 19762 9 . Moss, R.W., The Moss Reports, no. 127, April 4, 2004,h t t p : / / w w w . r a l p h m o s s . c o m3 0 . Moss, R.W., The Moss Reports, no. 86, June 7, 2003 3 1 . Moss, R.W., The Moss Reports, no. 122, February 28,2004 3 2 . Null, G., Dean, C. et al., "Death by Medicine",Nutrition Institute of America, November 2003,h t t p : / / w w w . N u t r i t i o n I n s t i t u t e O f A m e r i c a . . o r g3 3 . Smith, R. (editor), "The poverty of medical evidence",British Medical Journal,vol. 303, 5 October 19913 4 . Begley, Sharon, "New statistics show increase in can-cer rates: cancer rates go up, not down", Wall StreetJ o u r n a l, October 16, 2002, p. B13 5 . Hildenbrand, G.L. et al., "Five-year survival rates ofmelanoma patients treated by diet therapy after the mannerof Gerson: A retrospective review", Alt. Therapies1 ( 4 ) : 2 9 -37 (Sept 1995)

How Scientific Are Orthodox Cancer Treatments?

Continued from page 28

JUNE – JULY 2004 www.nexusmagazine.com NEXUS • 75